Literature DB >> 15499198

Kinetic studies of covalent binding between N-acetyl-L-cysteine and human serum albumin through a mixed-disulfide using an N-methylpyridinium polymer-based column.

Daisuke Harada1, Makoto Anraku, Hikaru Fukuda, Shinsaku Naito, Kumiko Harada, Ayaka Suenaga, Masaki Otagiri.   

Abstract

The binding properties of the disulfide covalent bond between N-acetyl-L-cysteine (NAC) and human serum albumin (HSA) were investigated. HSA, purified from either healthy subjects or renal failure patients, was incubated with NAC in buffer and analyzed by 4VP-EG-Me column chromatography, which can distinguish between the redox states of the only free thiol of HSA. Although intact HSA was found to consist of mainly three sub-types, marcaptoalbumin (HMA), cysteine-bound nonmercaptoalbumin (HNA(Cys)) and a further oxidized form (HNA(oxy)), the formation of a new type of nonmercaptoalbumin (HNA(NAC)) was confirmed after incubation with NAC. Interestingly, NAC rapidly dissociated Cys from HNA(Cys) and NAC itself bound very slowly to HSA. These findings suggest that the interaction between NAC and HSA proceeds in a 2-step processes. The first-order binding and dissociation rate constants of NAC to healthy HSA (k(on,NAC)) and Cys from healthy HNA(Cys) (k(off,Cys)) were approximately 0.0032 and 1.3 (h(-1)), respectively. On the other hand, HSA from renal failure patients showed decreased HMA and increased HNA(Cys). The k(on,NAC) and k(off,Cys) were 0.0094 and 0.45 (h(-1)), respectively, suggesting that the pathological state may affect the binding properties of HSA and NAC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15499198     DOI: 10.2133/dmpk.19.297

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  10 in total

Review 1.  Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties.

Authors:  K Oettl; R E Stauber
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

2.  Redox Potential-Sensitive N-Acetyl Cysteine-Prodrug Nanoparticles Inhibit the Activation of Microglia and Improve Neuronal Survival.

Authors:  Eleni Markoutsa; Peisheng Xu
Journal:  Mol Pharm       Date:  2017-04-04       Impact factor: 4.939

3.  Reversion of sulfenamide prodrugs in the presence of free thiol-containing proteins.

Authors:  Kwame W Nti-Addae; Jennifer S Laurence; Andria L Skinner; Valentino J Stella
Journal:  J Pharm Sci       Date:  2011-02-03       Impact factor: 3.534

4.  Effects of N-acetylcysteine supplementation on disease activity, oxidative stress, and inflammatory and metabolic parameters in rheumatoid arthritis patients: a randomized double-blind placebo-controlled trial.

Authors:  Kamal Esalatmanesh; Alireza Jamali; Roozbeh Esalatmanesh; Zahra Soleimani; Alireza Khabbazi; Aida Malek Mahdavi
Journal:  Amino Acids       Date:  2022-02-08       Impact factor: 3.520

5.  N-acetylcysteine reverses cardiac myocyte dysfunction in a rodent model of behavioral stress.

Authors:  Fangping Chen; Jessalyn M Hadfield; Chalak Berzingi; John M Hollander; Diane B Miller; Cody E Nichols; Mitchell S Finkel
Journal:  J Appl Physiol (1985)       Date:  2013-05-30

Review 6.  N-Acetylcysteine--a safe antidote for cysteine/glutathione deficiency.

Authors:  Kondala R Atkuri; John J Mantovani; Leonard A Herzenberg; Leonore A Herzenberg
Journal:  Curr Opin Pharmacol       Date:  2007-06-29       Impact factor: 5.547

7.  The MUC5B Mucin Is Involved in Paraquat-Induced Lung Inflammation.

Authors:  Hao Sun; Yunfei Jiang; Yang Song; Xiaomin Zhang; Jun Wang; Jinsong Zhang; Jian Kang
Journal:  Oxid Med Cell Longev       Date:  2020-07-16       Impact factor: 6.543

8.  N-Acetyl-Cysteine Regenerates Albumin Cys34 by a Thiol-Disulfide Breaking Mechanism: An Explanation of Its Extracellular Antioxidant Activity.

Authors:  Alessandra Altomare; Giovanna Baron; Maura Brioschi; Martina Longoni; Riccardo Butti; Edoardo Valvassori; Elena Tremoli; Marina Carini; Piergiuseppe Agostoni; Giulio Vistoli; Cristina Banfi; Giancarlo Aldini
Journal:  Antioxidants (Basel)       Date:  2020-04-28

9.  Riboceine Rescues Auranofin-Induced Craniofacial Defects in Zebrafish.

Authors:  Megan Leask; Catherine Carleton; Bryony Leeke; Trent Newman; Joseph Antoun; Mauro Farella; Julia Horsfield
Journal:  Antioxidants (Basel)       Date:  2021-12-08

10.  Complexity of NAC Action as an Antidiabetic Agent: Opposing Effects of Oxidative and Reductive Stress on Insulin Secretion and Insulin Signaling.

Authors:  Lital Argaev-Frenkel; Tovit Rosenzweig
Journal:  Int J Mol Sci       Date:  2022-03-09       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.